New Products to Treat Neglected Diseases Are on the Rise
November 17, 2009

Marketing Exclusivity for First–in–Class Drugs Has Shortened to 2.5 Years
September 9, 2009

Large Pharmaceutical Firms Are Getting More Drugs Into Development While Terminating Unpromising Candidates
July 22, 2009

New Drug R&D Increasingly Depends on Partnerships Between Drug Sponsors and Service Providers
July 8, 2009

Number of Therapeutic Peptides in Clinical Study Has Nearly Doubled Since the 1990s
May 20, 2009

Three–Quarters of U.S. Health Plans Reimburse for Off–Label Uses of Prescription Drugs
March 11, 2009

New Drug Development Still Takes Eight Years Despite Faster FDA Review
January 8, 2009